Clinical Trial Update: A Two Part Study of Peroral Insulin in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A two-part Phase 1/2 trial of an orally administered insulin for Type 2 diabetes has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Peroral insulin (insulin)

Snippet

Sponsor: Bows Pharmaceuticals AG | Conditions: Diabetes Mellitus | Phase 1, Phase 2 | Status: SUSPENDED